HB0658 restructures Maryland’s forensic review and post-release monitoring framework for certain individuals under the jurisdiction of the Maryland Department of Health. It repeals a requirement that forensic review boards send notice of their recommendations to the committed person and counsel within 10 days after issuing a recommendation, while preserving advance notice before board meetings. The bill also allows an authorized agent for the committed person to attend forensic review board meetings virtually, except for the final voting portion.
The bill creates a new Community Forensic Aftercare Program within the Department of Health. That program is charged with monitoring committed persons on conditional release, as well as certain individuals with mental illness or intellectual disability who are subject to court-ordered monitoring. It must conduct regular meetings with the person and the person’s mental health team, receive and report alleged violations of conditional release, file applications for changes in conditional release on behalf of the Department, and establish a community monitoring board to make recommendations or decisions on early termination, modification, extension, continued eligibility for conditional release, and out-of-state travel requests.
HB0658 also amends the Criminal Procedure Article to add the Community Forensic Aftercare Program as an entity authorized to apply for changes in conditional release. The bill sets out procedures for notice, recordkeeping, access to records by the committed person and counsel, and disclosure to the public defender in certain circumstances. It requires the Department to adopt regulations to implement both the forensic review board changes and the new aftercare program, and it delays the effective date until October 1, 2027.
The bill’s impact on state law is significant because it creates a new administrative structure for post-release forensic supervision and expands the Department’s role in monitoring compliance with conditional release orders. It also formalizes a new community monitoring board with licensed health care providers, written findings, quorum and voting rules, and authority over travel and release-related decisions. The measure affects the Maryland Department of Health, forensic review boards, courts, State’s Attorneys, public defenders, committed persons, and behavioral health providers involved in conditional release and competency-related monitoring.
The overall sentiment appears favorable, with the House committee reporting the bill favorably with amendments and the House adopting it. No recorded votes or committee transcripts are provided, so there is little direct evidence of opposition in the available materials. The main points of potential contention are the expansion of state monitoring authority, the role of the new program in release-related decisions, the handling of records and confidentiality, and the balance between public safety oversight and the rights of committed persons to participate through an authorized agent or counsel.
HB0658 amends the Criminal Procedure Article and adds a new subtitle to the Health–General Article, creating the Community Forensic Aftercare Program within the Maryland Department of Health. It changes procedures for forensic review boards, including notice and participation rules, and authorizes the new program to monitor conditional release, report violations, and seek changes to conditional release orders. The bill also establishes a community monitoring board with authority over release-related recommendations and out-of-state travel requests, and requires the Department to promulgate implementing regulations.
The available legislative history suggests the bill was generally well received. The House committee issued a favorable report with amendments, and the House adopted the bill. Because there are no transcripts or recorded votes included, there is no documented floor debate showing organized opposition, but the bill’s amendments indicate some refinement of its procedures and scope during committee consideration.
The likely areas of contention are the breadth of the new monitoring program’s authority, the extent to which it can influence conditional release decisions, and the privacy and disclosure rules governing records shared with courts, prosecutors, and defense counsel. Another possible point of debate is the role of authorized agents and virtual attendance at forensic review and monitoring board meetings, as well as whether the new structure appropriately balances treatment, supervision, and due process for committed persons.